Enlivex Therapeutics Ltd. (ENLV) Stock Ticker
ENLV right now
Market factors today
Unlock the full ENLV picture
About Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arises from sepsis. Additionally, Allocetra is being investigated in preclinical studies for its potential application in solid tumor therapy.
ENLV stock facts
| Ticker symbol | ENLV |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $10.1M |
| CEO | Oren Hershkovitz |
| Employees | 34 |
| Headquarters | Ness Ziona, TA, IL |
| IPO date | 2014-07-31 |
| Website | www.enlivex.com |
What you can see for ENLV on Tickr
Live ENLV price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ENLV report.
Rankings
FAQ
What is the ticker symbol for Enlivex Therapeutics Ltd.?
The ticker symbol for Enlivex Therapeutics Ltd. is ENLV, listed on the NASDAQ Capital Market.
What is ENLV?
Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arises…